Trump administration impacts
Key executive orders impacting operations at HHS health agencies
May 2
Navigating the Trump tariffs: Biopharma execs weigh in
May 1
Klobuchar reiterates opposition to Trump tariffs
Filling the NIH funding gap to protect biopharma research
‘Everything is possible’: Pharmas navigate US market uncertainties
US HHS touts NIH-developed universal vaccine platform
April 30
Senate hearing: US biomedical research at a crossroads
April 29
EO record among Day 100 Trump achievements
Advamed, Medtech Europe sound off on tariffs
April 28
April 25
Vaccine Integrity Project launched to tackle ‘unfortunate reality’
Med tech majors unfazed by tariffs
April 24
Clarification: Nonvoting industry adcom members still possible
US capital crunch pushes China biotechs to roundabout financings
April 23
US HHS axes women’s health research
Chinabio 2025: Europe-China pharma deals rise as US markets shut
Free trade zones not a simple workaround for tariffs
MDMA’s Leahey skeptical of reports of the demise of user fees
April 22
Roche follows other pharmas, committing $50B in US investment
Harvard fighting back with lawsuit against Trump administration
The BioWorld Insider podcast: Bracing for the impact of tariffs and grant cuts
April 21
Makary’s vision for slimmed-down US FDA somewhat reassuring
April 18
Budget woes ahead for US life sciences sector?
Ouch! Tariffs hit med tech harder than expected
April 17
Ouch! Tariffs hit med tech harder than expected
April 16
New Trump order zeroes in on drug prices
April 15
Impact of tariffs on supplies of semiconductor tough to calculate
April 14
Biopharma tariffs becoming more than a threat
April 11
Novartis boosting US manufacturing with $23B investment
April 10
Dems petition White House to ensure drug supply chains stay intact
Loss of experience at US FDA raises concerns as impact felt
April 9
Many US tariffs paused, pharma warned, EU put on notice
US-China trade war accelerates with biotech in the crosshairs
April 8
Experts cite deadly consequences of PEPFAR funding disruption
Markets lose ground as US Senate meets on Trump tariffs
Europe’s med-tech companies assessing implications of tariffs
Many med-tech company supply chains protected from tariffs
April 7
US court says no to NIH indirect rate cut, another suit filed
April 3
Impact of Trump tariffs on med tech proving difficult to anticipate
Biopharma exempt from US reciprocal tariffs, but not untouched
Tariffs pressure industry markets; uncertainty remains
Asia in firing line of Trump tariffs, but health care escapes largely unscathed
With ‘wholesale assault’ on research, bipartisan alarm at institutional failure
April 2
Trump cuts are 'gutting' research grants, 'destabilizing' science
US to impose ‘kind reciprocal’ tariffs on country-by-country basis
Kennedy called to Senate HELP hearing on HHS reorg
April 1
Where’s the ‘radical transparency’ Kennedy promised?
March 31
Marks’ departure intensifies regulatory uncertainty at US FDA
March 28
Australia looks to Asia as Trump administration threatens funding
Medidata CEO says digital therapeutics, drugs future of patient treatment
March 27
BIO survey points to ‘damaging impacts’ of Trump tariffs
HHS to cut staffing levels by 20,000 under efficiency initiative
March 26
Senate votes in Makary, Bhattacharya at FDA and NIH
March 25
Oz hits Wyden’s wall of skepticism in Senate CMS post hearing
March 24
CDC’s ACIP meeting rescheduled
March 21
EU seeking talented scientists amid US funding woes
March 19
Trump halves the FTC, firing Democratic commissioners
March 18
WHO looking to fill funding gap left by the US
March 14
Oz promises AI, innovation, lower drug prices if confirmed to lead CMS
Lost in trans-lation? Trump’s mouse charge doesn’t click
March 13
US CDC nomination withdrawn, reforms in the works
Just one more vote to go for FDA, NIH nominees
March 10
As tariffs threaten US imports of APIs, companies reshore manufacturing
CDC briefing: Trump cuts disrupt disease surveillance, deplete talent
March 6
US FDA nominee HELPed on the way to confirmation
March 5
Bhattacharya shares his vision for US NIH
March 4
Trump’s EOs keep coming as US agencies await new leadership
March 3
NIH changes set industry up for workforce, ideas drought
Pallone, DeGette push back on FDA, other HHS dismissals
Feb, 25
New admin toes the Biden line on Rx price negotiations
Feb. 24
US lawmakers tell Kennedy: No more ‘indiscriminate’ terminations
Feb. 21
Amid the chaos, focus on innovation, says Stifel’s Opler
Raft of FDA job cuts may slow med-tech approvals
Feb. 20
Still waiting for the dust to settle at US FDA, throughout HHS
Feb. 19
Pharmaceuticals named as tariff target, starting at 25%
Feb. 18
Thousands of US HHS staff terminated in name of efficiency
AAAS 2025: Former NIH head Bertagnolli sounds warning on funding cuts
Feb. 14
Trump administration an existential threat to science, warns AAAS chief
Feb. 13
NIH funding plans threaten to derail ‘synergistic partnership’
Uncertainty builds amid Kennedy confirmation, Trump’s orders
Feb. 11
Court orders full stop to US NIH slashing of indirect rates
Infographic: Indirect costs of NIH grants
BIO CEO 2025: Navigating from policy to innovation to patients
BIO CEO 2025: Cognition CEO debates policy while advancing CT-1812
Feb. 10
BIO CEO 2025: A ‘nice upswing’ in VC rounds, but uncertainty looms
Scientists warn NIH cost-cutting will impair research
Feb. 7
Trump’s executive orders stacking up, along with challenges
Trump administration presents a mixed picture for med tech
Admin's actions toward science agencies 'not a measured reappraisal'
Mixed reactions from Asia on biotech implications of Trump 2.0
Speculations rise on US tariff impact on global pharma industry
Feb. 5
Doctors group sues US CDC, FDA, HHS over data takedown
Feb. 4
Kennedy advances toward confirmation as HHS secretary
China blacklists Illumina as part of US tariffs counter
Feb. 3
One vote could keep RFK from getting out of committee
Jan. 29
Confirmation hearings begin for RFK as US HHS secretary
The science on vaccines and autism: no there there
FDA diversity-in-trials rules evaporate after ‘strident’ Trump EO
Jan. 23
Mum’s the word at US health agencies awaiting new leadership